| Title: |
A randomized multicenter open label phase II study to determine the safety and efficacy of induction therapy with imatinib (Glivec, formerly STI571) in comparison with standard induction chemotherapy in elderly (>55�years) patients with Philadelphia chromosome-positive (Ph+/BCR-ABL+) acute lymphoblastic leukemia (ALL) (CSTI571ADE 10) |
| Authors: |
Wassmann, B.; G�kbuget, N.; Scheuring, U. J.; Binckebanck, A.; Reutzel, R.; Gschaidmeier, H.; Hoelzer, D.; Ottmann, O. G.; Group, GMALL Study |
| Source: |
Annals of Hematology ; volume 82, issue 11, page 716-720 ; ISSN 0939-5555 1432-0584 |
| Publisher Information: |
Springer Science and Business Media LLC |
| Publication Year: |
2003 |
| Document Type: |
article in journal/newspaper |
| Language: |
unknown |
| DOI: |
10.1007/s00277-003-0728-8 |
| DOI: |
10.1007/s00277-003-0728-8.pdf |
| DOI: |
10.1007/s00277-003-0728-8/fulltext.html |
| Availability: |
http://dx.doi.org/10.1007/s00277-003-0728-8; http://link.springer.com/content/pdf/10.1007/s00277-003-0728-8.pdf; http://link.springer.com/article/10.1007/s00277-003-0728-8/fulltext.html; http://link.springer.com/content/pdf/10.1007/s00277-003-0728-8 |
| Rights: |
http://www.springer.com/tdm |
| Accession Number: |
edsbas.33326381 |
| Database: |
BASE |